Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Abnormal molecular signatures of inflammation, energy metabolism and vesicle biology in human Huntington disease peripheral tissues

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.03.475821Source: DataRank Database

Abnormal molecular signatures of inflammation, energy metabolism and vesicle biology in human Huntington disease peripheral tissues is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (38)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Kerstin Kojer,Tanja Hering,Daniel J. Lavery ORCID,Jian Chen ORCID,Nathalie Birth

Live enrichment

PubMed:21097893 OpenAlex:https://openalex.org/W4210319801

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5R01NS119471-02

Therapeutic potential of base editing strategies to convert CAG to CAA in Huntington's Disease

National Institutes of Health

Grant: 5R01NS105709-02

Genetic foundation for complete mutant allele-specific CRISPR in neurodegenerative diseases

National Institutes of Health

Grant: 1R01NS091161-01

Disease-Modifying Genes in Huntington's Diseae

Wellcome Trust

Grant: 200181

TREAT-HD: targeting neurodegeneration in Huntington's disease

greenLicense: CC BY

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2022/02/06/2022.02.03.475821.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.02.03.475821

repositoryhttps://doi.org/10.1101/2022.02.03.475821

repositoryhttps://boris-portal.unibe.ch/handle/20.500.12422/115671

Fields of Study

Genetic Neurodegenerative DiseasesMitochondrial Function and PathologyMuscle Physiology and Disorders0303 health sciences03 medical and health sciences

Keywords

BiologyDiseasePathogenesisTranscriptomeExtracellular vesicleInflammationHuntington's diseaseMetabolomicsProteomicsBioinformaticsMicrovesiclesGeneGeneticsGene expressionmicroRNAMedicineImmunologyPathologySNP sequencingiPSCQH301-705.5ResearchSkeletal muscleAdipose tissueNeurodegenerative DiseasesQH426-470Huntington DiseaseHumansNeurodegenerationBiology (General)TranscriptomicsEnergy MetabolismSkin

Sustainable Development Goals

SDG 3: 3. Good health